Table 3.
Effect of POL and POL-NPs on kidney oxidative stress and antioxidant enzymes in STZ-induced diabetic rats
| Group | LPO (nmol MDA/100 mg protein) |
SOD (U/g protein) |
CAT (U/mg protein) |
GSH (nmol/100 mg protein) |
|---|---|---|---|---|
| Parameter | ||||
| Control | 14.37 ± 1.10 | 7.33 ± 0.50 | 118.80 ± 0.94 | 76.63 ± 5.55 |
| Diabetic | 68.87 ± 3.08*** | 1.50 ± 0.16*** | 55.57 ± 1.47*** | 25.47 ± 1.44*** |
| Diabetic + POL | 29.27 ± 0.48+++ | 4.70 ± 0.73+++ | 95.33 ± 3.21+++ | 51.40 ± 1.67+++ |
| Diabetic + POL-NPs | 18.98 ± 0.60+++$$$ | 6.03 ± 0.50+++$$ | 108.13 ± 2.15+++$$$ | 67.13 ± 2.62+++$$ |
Values were expressed as mean ± standard error. ***P < 0.001, compared with normal control group. +++P < 0.001, compared with diabetic group. $$P < 0.01, $$$P < 0.001, compared with diabetic group treated with POL (Diabetic + POL). STZ: streptozotocin, POL: polydatin, POL-NPs: polydatin-loaded chitosan nanoparticles, LPO: Lipid peroxidation, MDA: malonaldehyde, SOD: superoxide dismutase, CAT: catalase, GSH: glutathione